Literature DB >> 19961392

Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study.

I-Min Lee1, Jennifer Lin, Amy J Castonguay, Nathaniel S Barton, Julie E Buring, Robert Y L Zee.   

Abstract

BACKGROUND: To date, no prospective epidemiological data are available, particularly in women, on mean leukocyte telomere length as a risk predictor.
METHODS: Using leukocyte DNA samples collected at baseline in a prospective cohort of over 28,000 initially healthy women, we examined the relationship between mean leukocyte telomere repeat copy number to single gene copy number (TSR) in 134 incident cases of colorectal carcinoma (CRC), and 357 matched controls; all were Caucasian.
RESULTS: The observed log(e)-transformed TSRs were similar between cases and controls (p=0.79). Using an adjusted analysis, we found no evidence for an association of the log(e)-TSRs with CRC risk [adjusted odds ratio (OR)=0.943, 95% confidence interval (CI)=0.647-1.376, p=0.762]. Stratified analysis by median follow-up time, or postmenopausal status also showed similar null findings.
CONCLUSIONS: In concordance with our previous findings in Caucasian men, the present study in Caucasian women found no evidence for an association of mean leukocyte telomere length with risk of incident CRC, further suggesting that leukocyte telomere length may not be a useful indicator for risk assessment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19961392      PMCID: PMC2818287          DOI: 10.1515/CCLM.2010.049

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  30 in total

1.  Telomere length inversely correlates with pulse pressure and is highly familial.

Authors:  E Jeanclos; N J Schork; K O Kyvik; M Kimura; J H Skurnick; A Aviv
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

Review 2.  Role of oxidative stress in telomere length regulation and replicative senescence.

Authors:  T von Zglinicki
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

3.  Telomere length regulation during postnatal development and ageing in Mus spretus.

Authors:  G M Coviello-McLaughlin; K R Prowse
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity.

Authors:  A Benetos; K Okuda; M Lajemi; M Kimura; F Thomas; J Skurnick; C Labat; K Bean; A Aviv
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

5.  C-reactive protein levels are not associated with increased risk for colorectal cancer in women.

Authors:  Shumin M Zhang; Julie E Buring; I-Min Lee; Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2005-03-15       Impact factor: 25.391

6.  High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.

Authors:  N Tatsumoto; E Hiyama; Y Murakami; Y Imamura; J W Shay; Y Matsuura; T Yokoyama
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

Review 7.  Telomere instability and cancer.

Authors:  J Arturo Londoño-Vallejo
Journal:  Biochimie       Date:  2007-07-24       Impact factor: 4.079

8.  Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage.

Authors:  Rosa Ana Risques; Lisa A Lai; Teresa A Brentnall; Lin Li; Ziding Feng; Jasmine Gallaher; Margaret T Mandelson; John D Potter; Mary P Bronner; Peter S Rabinovitch
Journal:  Gastroenterology       Date:  2008-04-15       Impact factor: 22.682

9.  Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.

Authors:  M Engelhardt; J Albanell; P Drullinsky; W Han; J Guillem; H I Scher; V Reuter; M A Moore
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531

10.  Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.

Authors:  M Engelhardt; P Drullinsky; J Guillem; M A Moore
Journal:  Clin Cancer Res       Date:  1997-11       Impact factor: 12.531

View more
  24 in total

Review 1.  Epidemiologic evidence for a role of telomere dysfunction in cancer etiology.

Authors:  Jennifer Prescott; Ingrid M Wentzensen; Sharon A Savage; Immaculata De Vivo
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

2.  Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.

Authors:  Shaogui Wan; Hie-Won Hann; Zhong Ye; Richard S Hann; Yinzhi Lai; Chun Wang; Ling Li; Ronald E Myers; Bingshan Li; Jinliang Xing; Hushan Yang
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

3.  Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.

Authors:  Andrew J Pellatt; Roger K Wolff; Abbie Lundgreen; Richard Cawthon; Martha L Slattery
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

4.  Telomere length in prospective and retrospective cancer case-control studies.

Authors:  Karen A Pooley; Manjinder S Sandhu; Jonathan Tyrer; Mitul Shah; Kristy E Driver; Robert N Luben; Sheila A Bingham; Bruce A J Ponder; Paul D P Pharoah; Kay-Tee Khaw; Douglas F Easton; Alison M Dunning
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

5.  The association of telomere length and cancer: a meta-analysis.

Authors:  Ingrid M Wentzensen; Lisa Mirabello; Ruth M Pfeiffer; Sharon A Savage
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

6.  Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study.

Authors:  Yong Cui; Qiuyin Cai; Shimian Qu; Wong-Ho Chow; Wanqing Wen; Yong-Bing Xiang; Jie Wu; Nathaniel Rothman; Gong Yang; Xiao-Ou Shu; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-21       Impact factor: 4.254

7.  Shorter peripheral blood telomeres are a potential biomarker for patients with advanced colorectal adenomas.

Authors:  Douglas L Riegert-Johnson; Lisa A Boardman; Julia E Crook; Colleen S Thomas; Ruth A Johnson; Maegan E Roberts
Journal:  Int J Biol Markers       Date:  2012-12-27       Impact factor: 2.659

Review 8.  Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Authors:  Nivedita Basu; Halcyon G Skinner; Kristin Litzelman; Russell Vanderboom; Esha Baichoo; Lisa A Boardman
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11       Impact factor: 3.869

9.  Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.

Authors:  Philip C Haycock; Stephen Burgess; Aayah Nounu; Jie Zheng; George N Okoli; Jack Bowden; Kaitlin Hazel Wade; Nicholas J Timpson; David M Evans; Peter Willeit; Abraham Aviv; Tom R Gaunt; Gibran Hemani; Massimo Mangino; Hayley Patricia Ellis; Kathreena M Kurian; Karen A Pooley; Rosalind A Eeles; Jeffrey E Lee; Shenying Fang; Wei V Chen; Matthew H Law; Lisa M Bowdler; Mark M Iles; Qiong Yang; Bradford B Worrall; Hugh Stephen Markus; Rayjean J Hung; Chris I Amos; Amanda B Spurdle; Deborah J Thompson; Tracy A O'Mara; Brian Wolpin; Laufey Amundadottir; Rachael Stolzenberg-Solomon; Antonia Trichopoulou; N Charlotte Onland-Moret; Eiliv Lund; Eric J Duell; Federico Canzian; Gianluca Severi; Kim Overvad; Marc J Gunter; Rosario Tumino; Ulrika Svenson; Andre van Rij; Annette F Baas; Matthew J Bown; Nilesh J Samani; Femke N G van t'Hof; Gerard Tromp; Gregory T Jones; Helena Kuivaniemi; James R Elmore; Mattias Johansson; James Mckay; Ghislaine Scelo; Robert Carreras-Torres; Valerie Gaborieau; Paul Brennan; Paige M Bracci; Rachel E Neale; Sara H Olson; Steven Gallinger; Donghui Li; Gloria M Petersen; Harvey A Risch; Alison P Klein; Jiali Han; Christian C Abnet; Neal D Freedman; Philip R Taylor; John M Maris; Katja K Aben; Lambertus A Kiemeney; Sita H Vermeulen; John K Wiencke; Kyle M Walsh; Margaret Wrensch; Terri Rice; Clare Turnbull; Kevin Litchfield; Lavinia Paternoster; Marie Standl; Gonçalo R Abecasis; John Paul SanGiovanni; Yong Li; Vladan Mijatovic; Yadav Sapkota; Siew-Kee Low; Krina T Zondervan; Grant W Montgomery; Dale R Nyholt; David A van Heel; Karen Hunt; Dan E Arking; Foram N Ashar; Nona Sotoodehnia; Daniel Woo; Jonathan Rosand; Mary E Comeau; W Mark Brown; Edwin K Silverman; John E Hokanson; Michael H Cho; Jennie Hui; Manuel A Ferreira; Philip J Thompson; Alanna C Morrison; Janine F Felix; Nicholas L Smith; Angela M Christiano; Lynn Petukhova; Regina C Betz; Xing Fan; Xuejun Zhang; Caihong Zhu; Carl D Langefeld; Susan D Thompson; Feijie Wang; Xu Lin; David A Schwartz; Tasha Fingerlin; Jerome I Rotter; Mary Frances Cotch; Richard A Jensen; Matthias Munz; Henrik Dommisch; Arne S Schaefer; Fang Han; Hanna M Ollila; Ryan P Hillary; Omar Albagha; Stuart H Ralston; Chenjie Zeng; Wei Zheng; Xiao-Ou Shu; Andre Reis; Steffen Uebe; Ulrike Hüffmeier; Yoshiya Kawamura; Takeshi Otowa; Tsukasa Sasaki; Martin Lloyd Hibberd; Sonia Davila; Gang Xie; Katherine Siminovitch; Jin-Xin Bei; Yi-Xin Zeng; Asta Försti; Bowang Chen; Stefano Landi; Andre Franke; Annegret Fischer; David Ellinghaus; Carlos Flores; Imre Noth; Shwu-Fan Ma; Jia Nee Foo; Jianjun Liu; Jong-Won Kim; David G Cox; Olivier Delattre; Olivier Mirabeau; Christine F Skibola; Clara S Tang; Merce Garcia-Barcelo; Kai-Ping Chang; Wen-Hui Su; Yu-Sun Chang; Nicholas G Martin; Scott Gordon; Tracey D Wade; Chaeyoung Lee; Michiaki Kubo; Pei-Chieng Cha; Yusuke Nakamura; Daniel Levy; Masayuki Kimura; Shih-Jen Hwang; Steven Hunt; Tim Spector; Nicole Soranzo; Ani W Manichaikul; R Graham Barr; Bratati Kahali; Elizabeth Speliotes; Laura M Yerges-Armstrong; Ching-Yu Cheng; Jost B Jonas; Tien Yin Wong; Isabella Fogh; Kuang Lin; John F Powell; Kenneth Rice; Caroline L Relton; Richard M Martin; George Davey Smith
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

10.  Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status.

Authors:  Karen A Pooley; Lesley McGuffog; Daniel Barrowdale; Debra Frost; Steve D Ellis; Elena Fineberg; Radka Platte; Louise Izatt; Julian Adlard; Julian Bardwell; Carole Brewer; Trevor Cole; Jackie Cook; Rosemarie Davidson; Alan Donaldson; Huw Dorkins; Fiona Douglas; Jacqueline Eason; Catherine Houghton; M John Kennedy; Emma McCann; Zosia Miedzybrodzka; Alex Murray; Mary E Porteous; Mark T Rogers; Lucy E Side; Marc Tischkowitz; Lisa Walker; Shirley Hodgson; Diana M Eccles; Patrick J Morrison; D Gareth Evans; Rosalind A Eeles; Antonis C Antoniou; Douglas F Easton; Alison M Dunning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-18       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.